Amyloid and tau imaging in neuromuscular diseases

Amyloid and tau imaging in neuromuscular diseases - Amyloid- and tau-PET in neuromuscular diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036278

Enrollment

Registered

2019-04-01

Start date

2014-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inclusion body myositis, inflammatory myositis, distal myopathy, muscular dystrophy, amyotrophic lateral sclerosis

Interventions

PET imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with inclusion body myositis, inflammatory myopathy, distal myopathy, muscular dystrophy, amyotrophic lateral sclerosis

Exclusion criteria

Exclusion criteria: Patients accompanied by the disease that affects the main pathogenesis of muscular diseases.

Design outcomes

Primary

Measure	Time frame
The distribution pattern of PIB and FDDNP in limb and truncal muscle.	—

Countries

Japan

Contacts

Public ContactYu-ichi Noto

Graduate School of Medical Science, Kyoto Prefectural University of Medicine Department of Neurology

y-noto@koto.kpu-m.ac.jp075-251-5794

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026